Back to Journals » OncoTargets and Therapy » Volume 6

Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

Total article views   Abstract views HTML views PDF downloads Totals
12,914 Dovepress* 8,199 756+ 2,716 8,955
PubMed Central* 10 3,949 1,566 3,959
Totals 8,209 4,705 4,282 12,914
*Since 5 November 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar